Trial Profile
A Single-Dose, Randomized, Placebo-Controlled, Double-Blind, Crossover Study Investigating the Effect of Cannabidiol (CBD) on Cardiovascular Parameters in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2017
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2017 New trial record
- 02 Jun 2017 Results published in the Journal of Clinical Investigation Insight.